NCT04710550View on ClinicalTrials.gov

Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Brain Injuries, TraumaticDemyelinating DisorderAlzheimer Disease
Interventions
DRUG

F18-3F4AP

PET Scan

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT04710550 - Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury | Biotech Hunter | Biotech Hunter